Find Funding Opportunities

Excellent mentorship and superior training are critical to the development of exceptional future scientists. To recognize the crucial role great mentors play in the development of future leaders in neuroscience, the National Institute of Neurological Disorders and Stroke (NINDS) created the Landis Award for Outstanding Mentorship. Each year, this award provides $100,000.00 (direct costs) to up to five (5) faculty members, who have demonstrated a dedication to outstanding mentorship and training. This funding is intended to help foster the research career development of current or additional students and post-doctorates under the guidance of outstanding mentors. NINDS hopes that this tangible award will impress upon the scientific community as a whole, and faculty and institutional leaders in particular, the high value NINDS places on outstanding training and mentorship. Further, NINDS hopes that it encourages institutions to reward individuals not only for outstanding research accomplishments but also for their impact on the lives of others, and the future of neuroscience, through outstanding mentorship and training.

The purpose of this Notice of Change is to inform current and future recipients of the NINDS R35 Research Program Award (RPA) of a change to the opportunity to request a budget increase based on exceptional circumstances at the year five (5) administrative review.

The BP BRAIN-ENDURE R25 aims to raise interest and opportunities in neuroscience research for individuals who are typically underrepresented in the field. The goal of this program is to provide such individuals with training at the undergraduate level, so that they are prepared to enter and successfully complete neuroscience Ph.D. programs. The initiative will support two-year neuroscience research education experiences comprised of year-round authentic neuroscience research projects, research and career development, and establishment of professional networks, implemented through collaborative partnerships integrated across different educational institution types. ENDURE will provide this undergraduate training through partnerships between research-intensive institutions and institutions with a substantial enrollment of neuroscience majors from diverse groups.

The purpose of this notice is to inform applicants of the early termination of PAR-22-184 "NINDS/NCATS Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases".

Ethical considerations are intrinsic to the responsible conduct of neuroscience research and the translation of neuroscience advances (scientific and technological) into practice. This Notice of Special Interest (NOSI) highlights interest in receiving grant applications to advance research on ethical questions relevant to the NINDS mission of pursuing important work to gain a deeper understanding of the brain and nervous system to develop effective therapies for all people.

The purpose of this notice of correction is to inform applicants of the removal of the basic science experimental studies (BESH) language from PAR-24-219 NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Not Allowed). Clinical Trials, including BESH, are not allowed under this notice of funding opportunity (NOFO).

The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH) intend to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) that solicits applications focused on the neurological and psychiatric manifestations of infection-associated chronic illnesses, including the post-acute sequelae of COVID-19 (Neuro-PASC) as well as other chronic illnesses with a potential infectious trigger (post-treatment Lyme Disease, myalgic encephalomyelitis/chronic fatigue syndrome [ME/CFS], postural orthostatic tachycardia syndrome [POTS], post-viral fatigue syndromes, etc.). Projects that investigate common neuropsychiatric mechanisms across multiple infection-associated chronic illnesses would be of particular interest, although this is not a requirement (i.e., applications can focus on a single condition).

The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH) intend to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) that solicits applications focused on the neurological and psychiatric manifestations of infection-associated chronic illnesses, including the post-acute sequelae of COVID-19 (Neuro-PASC) as well as other chronic illnesses with a potential infectious trigger (post-treatment Lyme Disease, myalgic encephalomyelitis/chronic fatigue syndrome [ME/CFS], postural orthostatic tachycardia syndrome [POTS], post-viral fatigue syndromes, etc.). Projects that investigate common neuropsychiatric mechanisms across multiple infection-associated chronic illnesses would be of particular interest, although this is not a requirement (i.e., applications can focus on a single condition).

This Request for Information (RFI) seeks your perspective, comments, and suggestions related to Neural Exposome research priorities for the National Institute of Neurological Disorders and Stroke (NINDS). A working group of NINDS's advisory council has developed a set of draft priorities to guide NINDS's neural exposome research efforts for the next 5-10 years. 

Extending the exp. date to 7/31/24.